Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France

Authors not listed

University Hospital, Brest · 2018

Abstract

Neuroendocrine cancer remains a poorly known entity. Comprehensive treatment is multidisciplinary involving surgery, radiological and nuclear medicine, and medical. A national network for the management of sporadic and hereditary malignant neuro-ENdocrine Tumor (RENATEN) is in charged of coordinating this specific care. This is part of the French National Cancer INstitute (INCa) Rare Cancer Plan. The project is in the form of an analysis of elderly population (75 years or over) with a diagnosis of neuroendocrine cancer in the western part of the France (Brittany, Pays de Loire, Normandy, Center and a part of New Aquitaine areas) representing a population of more than 12 millions of inhabitants. Oncogeriatric evaluations, specialized meetings, ...would be analysed in order to improve the care of rare cancer patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Anonymous. (2018). Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France. <em>University Hospital, Brest</em>. https://clinicaltrials.gov/study/NCT03749681
Vancouver
Anonymous. Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France. University Hospital, Brest. 2018.
BibTeX
@misc{anon2018Neuroe, title = {Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France}, author = {Anonymous}, journal = {University Hospital, Brest}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings